Effects of sevelamer and calcium‐based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: A randomized clinical trial - Concepedia

Concepedia

Publication | Closed Access

Effects of sevelamer and calcium‐based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: A randomized clinical trial

113

Citations

24

References

2005

Year

Jay Garg, Scott Chasan‐Taber, Andrew T. Blair, Melissa A. Plone, Juergen Bommer, Paolo Raggi, Glenn M. Chertow

Arthritis & Rheumatism

Abstract

In a randomized clinical trial comparing sevelamer and calcium-based phosphate binders, treatment with sevelamer was associated with a significant reduction in serum uric acid concentrations.

References

	Year	Citations
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, The Lancet HypertensionCardiovascular DiseaseEndpoint ReductionRandomised TrialAntihypertensive Therapy	2002	5.4K
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Glenn M. Chertow, Steven K. Burke, Paolo Raggi, Kidney International ThrombosisHemodialysisUrologyRenal FunctionHemodialysis Patients	2002	1.5K
The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis Dennis M. Black, Susan L. Greenspan, Kristine E. Ensrud, New England Journal of Medicine	2003	1.2K
Hyperuricemia in Primary and Renal Hypertension Paul J. Cannon, William B. Stason, Felix E. Demartini, New England Journal of Medicine HypertensionUrologyRenal DiseaseRenal FunctionSodium Homeostasis	1966	505
Serum Uric Acid in Essential Hypertension: An Indicator of Renal Vascular Involvement Franz H. Messerli Annals of Internal Medicine	1980	464
Colchicine Myopathy and Neuropathy Ralph W. Kuncl, Greg J. Duncan, Danny F. Watson, New England Journal of Medicine	1987	429
Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) Lonneke V. Franse, Marco Pahor, Mauro Di Bari, Journal of Hypertension	2000	306
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Eduardo A. Slatopolsky, Steven K. Burke, Maureen Dillon Kidney International UrologySodium HomeostasisMedicinePhysiologyPharmacology	1999	303
Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients* Glenn M. Chertow, Steven K. Burke, Maureen Dillon, Nephrology Dialysis Transplantation	1999	299
Determinants of progressive vascular calcification in haemodialysis patients Glenn M. Chertow, Paolo Raggi, Scott Chasan-Taber, Nephrology Dialysis Transplantation	2004	284

Page 1